0001104659-21-151112.txt : 20211217
0001104659-21-151112.hdr.sgml : 20211217
20211217160201
ACCESSION NUMBER: 0001104659-21-151112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20211217
DATE AS OF CHANGE: 20211217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gagnon Robert E.
CENTRAL INDEX KEY: 0001504983
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 211501443
MAIL ADDRESS:
STREET 1: C/O BIOGEN IDEC INC.
STREET 2: 133 BOSTON POST ROAD
CITY: WESTON
STATE: MA
ZIP: 02493
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
tm2135712-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-08-12
0
0001526119
Verastem, Inc.
VSTM
0001504983
Gagnon Robert E.
C/O VERASTEM, INC., 117 KENDRICK ST.,
SUITE 500
NEEDHAM
MA
02494
0
1
0
0
Chief Financial Officer
Common Stock
2021-08-12
4
F
0
45329
2.87
D
435898
D
Common Stock
2021-12-15
4
A
0
148500
0
A
584398
D
Stock Option (Right to Buy)
2.36
2021-12-15
4
A
0
301500
0
A
2031-12-15
Common Stock
301500
301500
D
The total reflects the disposition of 45,329 shares sold by the Issuer to satisfy statutory withholding requirements upon vesting of restricted stock units and additional reductions of 74,981 shares previously retired and 18,760 shares previously sold, in each case by the Issuer, to satisfy statutory withholding requirements upon vesting of restricted stock units. The total also reflects 3,333 shares purchased under the Issuer's Employee Stock Purchase Plan.
Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of December 15, 2021 (the "RSU Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the RSU Grant Date until the fourth anniversary of the RSU Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.
The option vests as to 25% of the shares on the first anniversary of December 15, 2021 (the "Option Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Option Grant Date until the fourth anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.
/s/ Robert E. Gagnon, Attorney-in-Fact
2021-12-17